Table 4.
Parameters | HR (95% Cl) | P value |
---|---|---|
LIMCH1 expression | 5.3116 (2.5356; 11.1267) | 0.00001 |
presence vs absence | ||
Limphogenous metastases: | 712 (1.9516; 9.3480) | 0.0003 |
presence vs absence | ||
NACT: | 1.2302 (0.5997; 2.5237) | 0.5720 |
presence vs absence | ||
N: | 1.5921 (0.1957; 12.9537) | 0.5407 |
N3 vs N0 | 3.5506 (0.4241; 12.9537) | 0.1244 |
N2 vs N0 | 3.4130 (0.5154; 22.6008) | 0.5438 |
N1 vs N0 | ||
Grade: | 0.9921 (0.3391; 2.9025) | 0.9884 |
3 vs 2 | ||
T: | 3.6937 (1.7557; 7.7707) | 0.0006 |
T3-4 vs T1-2 | ||
Tumor size: | 2.7302 (0.7170; 10.3957) | 0.0797 |
>50 mm vs <20 mm | 1.0017 (0.3623; 2.7690) | 0.2392 |
20– 50 mm vs <20 mm | ||
Menstrual status: | 0.5976 (0.2767; 1.2908) | 0.1901 |
Menopause vs pre-menopause | ||
Age: | 0.4583 (0.1531; 1.3716) | 0.2334 |
>50 vs <35 | 0.5219 (0.1651; 1.6498) | 0.5281 |
35-50 vs <35 |